Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 712 | 407 | 705 | 700 | 0 |
| Cost of Goods | 52 | 301 | 604 | 511 | N/A |
| Gross Profit | 660 | 105 | 101 | 189 | N/A |
| Operating Expenses | 29,858 | 3,053 | 14,320 | 11,782 | 22,107 |
| Operating Income | -29,146 | -2,646 | -13,615 | -11,082 | -22,049 |
| Interest Expense | 248 | 385 | 361 | 413 | 189 |
| Other Income | -962 | -853 | -280 | 255 | -126 |
| Pre-tax Income | -30,356 | -3,884 | -14,256 | -11,240 | -22,364 |
| Income Tax | -918 | -56 | 51 | -122 | N/A |
| Net Income Continuous | -29,438 | -3,827 | -14,307 | -11,119 | -22,351 |
| Net Income | $-29,438 | $-3,827 | $-14,307 | $-11,119 | $-22,351 |
| EPS Basic Total Ops | 115,948.70 | -12,454.00 | -109,579.50 | -85,084.73 | -318,812.90 |
| EPS Basic Continuous Ops | 116,271.90 | -12,454.13 | -109,579.50 | -85,088.38 | -318,827.70 |
| EPS Diluted Total Ops | 115,948.70 | -12,454.00 | -109,579.50 | -85,084.73 | -318,812.90 |
| EPS Diluted Continuous Ops | 116,271.90 | -12,454.13 | -109,579.50 | -85,088.38 | -318,827.70 |
| EPS Diluted Before Non-Recurring Items | N/A | -9,491.53 | -38,983.05 | N/A | N/A |
| EBITDA(a) | $-18,376 | $-2,256 | $-13,186 | $-10,518 | $-21,880 |